πŸ‡ΊπŸ‡Έ FDA
Patent

US 11584748

Spirocyclic compounds

granted A61PA61P35/00

Quick answer

US patent 11584748 (Spirocyclic compounds) held by C4 THERAPEUTICS, INC. expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
C4 THERAPEUTICS, INC.
Grant date
Tue Feb 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P35/00